{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T19:44:24Z","timestamp":1770061464407,"version":"3.49.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T00:00:00Z","timestamp":1734912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T00:00:00Z","timestamp":1734912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"\u201cScience and Technology Innovation Action Plan\u201d Star Cultivation","award":["22YF1443600"],"award-info":[{"award-number":["22YF1443600"]}]},{"DOI":"10.13039\/501100002858","name":"the China Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["2023M732230"],"award-info":[{"award-number":["2023M732230"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"DOI":"10.1186\/s12880-024-01539-3","type":"journal-article","created":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T16:18:32Z","timestamp":1734970712000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Identification of SMAD4-mutated pancreatic ductal adenocarcinoma using preoperative contrast-enhanced MRI and clinical characteristics"],"prefix":"10.1186","volume":"24","author":[{"given":"Zhina","family":"Li","sequence":"first","affiliation":[]},{"given":"Cheng","family":"Wang","sequence":"additional","affiliation":[]},{"given":"Jianbo","family":"Li","sequence":"additional","affiliation":[]},{"given":"Xingxing","family":"Wang","sequence":"additional","affiliation":[]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[]},{"given":"Tianzhu","family":"Yu","sequence":"additional","affiliation":[]},{"given":"Jianjun","family":"Zhou","sequence":"additional","affiliation":[]},{"given":"Xiaolin","family":"Wang","sequence":"additional","affiliation":[]},{"given":"Mengsu","family":"Zeng","sequence":"additional","affiliation":[]},{"given":"Haitao","family":"Sun","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2024,12,23]]},"reference":[{"issue":"8","key":"1539_CR1","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","volume":"186","author":"CJ Halbrook","year":"2023","unstructured":"Halbrook CJ, Lyssiotis CA, Pasca Di Magliano M, Maitra A. Pancreatic cancer: advances and challenges. Cell. 2023;186(8):1729\u201354.","journal-title":"Cell"},{"issue":"5","key":"1539_CR2","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3322\/caac.21626","volume":"70","author":"AJ Grossberg","year":"2020","unstructured":"Grossberg AJ, Chu LC, Deig CR, Fishman EK, Hwang WL, Maitra A, Marks DL, Mehta A, Nabavizadeh N, Simeone DM, et al. Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma. Cancer J Clin. 2020;70(5):375\u2013403.","journal-title":"Cancer J Clin"},{"issue":"2","key":"1539_CR3","doi-asserted-by":"publisher","first-page":"101391","DOI":"10.1016\/j.xcrm.2023.101391","volume":"5","author":"H Yamazaki","year":"2024","unstructured":"Yamazaki H, Streicher SA, Wu L, Fukuhara S, Wagner R, Heni M, Grossman SR, Lenz H, Setiawan VW, Le Marchand L, et al. Evidence for a causal link between intra-pancreatic fat deposition and pancreatic cancer: a prospective cohort and mendelian randomization study. CELL REP MED. 2024;5(2):101391.","journal-title":"CELL REP MED"},{"issue":"16","key":"1539_CR4","doi-asserted-by":"publisher","first-page":"6931","DOI":"10.7150\/thno.77949","volume":"12","author":"B Huang","year":"2022","unstructured":"Huang B, Huang H, Zhang S, Zhang D, Shi Q, Liu J, Guo J. Artificial intelligence in pancreatic cancer. THERANOSTICS. 2022;12(16):6931\u201354.","journal-title":"THERANOSTICS"},{"key":"1539_CR5","doi-asserted-by":"crossref","unstructured":"Dardare J, Witz A, Merlin JL, Gilson P, Harl\u00e9 A. SMAD4 and the TGF\u03b2 pathway in patients with pancreatic ductal adenocarcinoma. INT J MOL SCI 2020, 21(10).","DOI":"10.3390\/ijms21103534"},{"issue":"2","key":"1539_CR6","doi-asserted-by":"publisher","first-page":"111","DOI":"10.7150\/ijbs.23230","volume":"14","author":"M Zhao","year":"2018","unstructured":"Zhao M, Mishra L, Deng CX. The role of TGF-\u03b2\/SMAD4 signaling in cancer. INT J BIOL SCI. 2018;14(2):111\u201323.","journal-title":"INT J BIOL SCI"},{"issue":"10","key":"1539_CR7","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.3748\/wjg.v21.i10.2988","volume":"21","author":"J Zhang","year":"2015","unstructured":"Zhang J, Zuo CJ, Jia NY, Wang JH, Hu SP, Yu ZF, Zheng Y, Zhang AY, Feng XY. Cross-modality PET\/CT and contrast-enhanced CT imaging for pancreatic cancer. WORLD J GASTROENTERO. 2015;21(10):2988\u201396.","journal-title":"WORLD J GASTROENTERO"},{"issue":"12","key":"1539_CR8","first-page":"4115","volume":"7","author":"M Tascilar","year":"2001","unstructured":"Tascilar M, Skinner HG, Rosty C, Sohn T, Wilentz RE, Offerhaus GJ, Adsay V, Abrams RA, Cameron JL, Kern SE, et al. The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma. CLIN CANCER RES. 2001;7(12):4115\u201321.","journal-title":"CLIN CANCER RES"},{"issue":"5","key":"1539_CR9","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1136\/gutjnl-2018-317163","volume":"69","author":"C Liang","year":"2020","unstructured":"Liang C, Shi S, Qin Y, Meng Q, Hua J, Hu Q, Ji S, Zhang B, Xu J, Yu X. Localisation of PGK1 determines metabolic phenotype to balance metastasis and proliferation in patients with SMAD4-negative pancreatic cancer. Gut. 2020;69(5):888\u2013900.","journal-title":"Gut"},{"key":"1539_CR10","doi-asserted-by":"crossref","unstructured":"Kassardjian A, Wang HL. SMAD4-Expressing Pancreatic Ductal Adenocarcinomas Have Better Response to Neoadjuvant Therapy and Significantly Lower Lymph Node Metastasis Rates. PANCREAS 2020, 49(9):1153\u20131160.","DOI":"10.1097\/MPA.0000000000001636"},{"key":"1539_CR11","doi-asserted-by":"crossref","unstructured":"Principe DR, Underwood PW, Kumar S, Timbers KE, Koch RM, Trevino JG, Munshi HG, Rana A. Loss of SMAD4 is Associated with Poor Tumor Immunogenicity and reduced PD-L1 expression in pancreatic Cancer. FRONT ONCOL 2022, 12.","DOI":"10.3389\/fonc.2022.806963"},{"issue":"11","key":"1539_CR12","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/s41419-024-07210-7","volume":"15","author":"Y Wang","year":"2024","unstructured":"Wang Y, Yu T, Zhao Z, Li X, Song Y, He Y, Zhou Y, Li P, An L, Wang F. SMAD4 limits PARP1 dependent DNA repair to render pancreatic Cancer cells sensitive to Radiotherapy. CELL DEATH DIS. 2024;15(11):818.","journal-title":"CELL DEATH DIS"},{"issue":"6","key":"1539_CR13","doi-asserted-by":"publisher","first-page":"189220","DOI":"10.1016\/j.bbcan.2024.189220","volume":"1879","author":"H Yao","year":"2024","unstructured":"Yao H, Luo L, Li R, Zhao Y, Zhang L, Pe\u0161i\u0107 M, Cai L, Li L. New insight into the role of SMAD4 mutation\/deficiency in the prognosis and therapeutic resistance of pancreatic ductal adenocarcinomas. Biochim et Biophys Acta (BBA) - Reviews Cancer. 2024;1879(6):189220.","journal-title":"Biochim et Biophys Acta (BBA) - Reviews Cancer"},{"key":"1539_CR14","doi-asserted-by":"crossref","unstructured":"Ronot M, Chernyak V, Burgoyne A, Chang J, Jiang H, Bashir M, Fowler KJ. Imaging to Predict Prognosis in Hepatocellular Carcinoma: Current and Future Perspectives. RADIOLOGY 2023, 307(3):e221429.","DOI":"10.1148\/radiol.221429"},{"key":"1539_CR15","doi-asserted-by":"crossref","unstructured":"Jansen RW, de Bloeme CM, Cardoen L, G\u00f6ricke S, van Elst S, Jessen JL, Ramasubramanian A, Skalet AH, Miller AK, Maeder P et al. MRI features for identifying MYCN -amplified RB1 wild-type Retinoblastoma. Radiology 2023:222264.","DOI":"10.26226\/m.6304a252fa816f364423c564"},{"issue":"2","key":"1539_CR16","doi-asserted-by":"publisher","first-page":"e220531","DOI":"10.1148\/radiol.220531","volume":"306","author":"A Kitao","year":"2023","unstructured":"Kitao A, Matsui O, Zhang Y, Ogi T, Nakada S, Sato Y, Harada K, Yoneda N, Kozaka K, Inoue D, et al. Dynamic CT and Gadoxetic Acid-enhanced MRI characteristics of P53-mutated Hepatocellular Carcinoma. Radiology. 2023;306(2):e220531.","journal-title":"Radiology"},{"key":"1539_CR17","doi-asserted-by":"crossref","unstructured":"Patel SH, Batchala PP, Mrachek E, Lopes MS, Schiff D, Fadul CE, Patrie JT, Jain R, Druzgal TJ, Williams ES. MRI and CT Identify Isocitrate Dehydrogenase (IDH)-Mutant Lower-Grade Gliomas Misclassified to 1p\/19q Codeletion Status with Fluorescence in Situ Hybridization. RADIOLOGY 2020, 294(1):160\u2013167.","DOI":"10.1148\/radiol.2019191140"},{"key":"1539_CR18","doi-asserted-by":"crossref","unstructured":"Bengtsson A, Andersson R, Ansari D. Histological variants of pancreatic ductal adenocarcinoma: a survival analysis. Langenbeck\u2019s Archives Surg 2024, 409(1).","DOI":"10.1007\/s00423-024-03506-6"},{"key":"1539_CR19","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.clinimag.2020.11.041","volume":"73","author":"K Schawkat","year":"2021","unstructured":"Schawkat K, Tsai LL, Jaramillo-Cardoso A, Paez SN, Moser JA, Decicco C, Singer T, Glickman J, Brook A, Manning MA, et al. Use of ring-enhancement and focal necrosis to differentiate pancreatic adenosquamous carcinoma from pancreatic ductal adenocarcinoma on CT and MRI. CLIN IMAG. 2021;73:134\u20138.","journal-title":"CLIN IMAG"},{"issue":"3","key":"1539_CR20","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1007\/s00261-015-0616-4","volume":"41","author":"F Toshima","year":"2016","unstructured":"Toshima F, Inoue D, Yoshida K, Yoneda N, Minami T, Kobayashi S, Ikdeda H, Matsui O, Gabata T. Adenosquamous carcinoma of pancreas: CT and MR imaging features in eight patients, with pathologic correlations and comparison with adenocarcinoma of pancreas. ABDOM RADIOL. 2016;41(3):508\u201320.","journal-title":"ABDOM RADIOL"},{"issue":"9","key":"1539_CR21","doi-asserted-by":"publisher","first-page":"3148","DOI":"10.1007\/s00261-019-02112-1","volume":"44","author":"MA Attiyeh","year":"2019","unstructured":"Attiyeh MA, Chakraborty J, McIntyre CA, Kappagantula R, Chou Y, Askan G, Seier K, Gonen M, Basturk O, Balachandran VP, et al. CT radiomics associations with genotype and stromal content in pancreatic ductal adenocarcinoma. ABDOM RADIOL. 2019;44(9):3148\u201357.","journal-title":"ABDOM RADIOL"},{"issue":"24","key":"1539_CR22","doi-asserted-by":"publisher","first-page":"6224","DOI":"10.3390\/cancers14246224","volume":"14","author":"R Hinzpeter","year":"2022","unstructured":"Hinzpeter R, Kulanthaivelu R, Kohan A, Avery L, Pham N, Ortega C, Metser U, Haider M, Veit-Haibach P. CT Radiomics and whole genome sequencing in patients with pancreatic ductal adenocarcinoma: predictive radiogenomics modeling. CANCERS. 2022;14(24):6224.","journal-title":"CANCERS"},{"issue":"12","key":"1539_CR23","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.1016\/j.acra.2023.03.007","volume":"30","author":"X Bai","year":"2023","unstructured":"Bai X, Wu L, Dai J, Wang K, Shi H, Lu Z, Ji G, Yu J, Xu Q. Rim Enhancement and Peripancreatic Fat Stranding in Preoperative MDCT as predictors for Occult Metastasis in PDAC patients. ACAD RADIOL. 2023;30(12):2954\u201361.","journal-title":"ACAD RADIOL"},{"key":"1539_CR24","doi-asserted-by":"crossref","unstructured":"Yoon SH, Lee JM, Cho JY, Lee KB, Kim JE, Moon SK, Kim SJ, Baek JH, Kim SH, Kim SH et al. Small (\u2264\u200920\u00a0mm) pancreatic adenocarcinomas: analysis of enhancement patterns and secondary signs with multiphasic multidetector CT. RADIOLOGY 2011, 259(2):442\u2013452.","DOI":"10.1148\/radiol.11101133"},{"issue":"2","key":"1539_CR25","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1007\/s00330-021-08147-7","volume":"32","author":"SK Venkatesh","year":"2022","unstructured":"Venkatesh SK, Welle CL, Miller FH, Jhaveri K, Ringe KI, Eaton JE, Bungay H, Arriv\u00e9 L, Ba-Ssalamah A, Grigoriadis A, et al. Reporting standards for primary sclerosing cholangitis using MRI and MR Cholangiopancreatography: guidelines from MR Working Group of the International Primary Sclerosing Cholangitis Study Group. EUR RADIOL. 2022;32(2):923\u201337.","journal-title":"EUR RADIOL"},{"key":"1539_CR26","doi-asserted-by":"crossref","unstructured":"Lee S, Kim SH, Park HK, Jang KT, Hwang JA, Kim S. Pancreatic Ductal Adenocarcinoma: Rim Enhancement at MR Imaging Predicts Prognosis after Curative Resection. RADIOLOGY 2018, 288(2):456\u2013466.","DOI":"10.1148\/radiol.2018172331"},{"issue":"2","key":"1539_CR27","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/jmri.26603","volume":"50","author":"H Sun","year":"2019","unstructured":"Sun H, Zhang S, Liu K, Zhou J, Wang X, Shen T, Song X, Guo Y, Wang X. MRI-based nomogram estimates the risk of recurrence of primary nonmetastatic pancreatic neuroendocrine tumors after curative resection. J MAGN RESON IMAGING. 2019;50(2):397\u2013409.","journal-title":"J MAGN RESON IMAGING"},{"key":"1539_CR28","doi-asserted-by":"publisher","first-page":"1304187","DOI":"10.3389\/fonc.2024.1304187","volume":"14","author":"MH Choi","year":"2024","unstructured":"Choi MH, Yoon SB, Lee YJ, Jung ES, Pak S, Han D, Nickel D. Rim enhancement of pancreatic ductal adenocarcinoma: investigating the relationship with DCE-MRI-based radiomics and next-generation sequencing. FRONT ONCOL. 2024;14:1304187.","journal-title":"FRONT ONCOL"},{"key":"1539_CR29","doi-asserted-by":"publisher","first-page":"632130","DOI":"10.3389\/fonc.2021.632130","volume":"11","author":"J Gao","year":"2021","unstructured":"Gao J, Chen X, Li X, Miao F, Fang W, Li B, Qian X, Lin X. Differentiating TP53 mutation status in pancreatic ductal adenocarcinoma using Multiparametric MRI-Derived Radiomics. FRONT ONCOL. 2021;11:632130.","journal-title":"FRONT ONCOL"},{"issue":"10","key":"1539_CR30","doi-asserted-by":"publisher","first-page":"101551","DOI":"10.1016\/j.isci.2020.101551","volume":"23","author":"Y Li","year":"2020","unstructured":"Li Y, Basti A, Yal\u00e7in M, Rel\u00f3gio A. Circadian dysregulation of the TGF\u03b2\/SMAD4 pathway modulates metastatic properties and Cell Fate decisions in pancreatic Cancer cells. ISCIENCE. 2020;23(10):101551.","journal-title":"ISCIENCE"},{"issue":"7","key":"1539_CR31","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/s41575-021-00463-z","volume":"18","author":"A Hayashi","year":"2021","unstructured":"Hayashi A, Hong J, Iacobuzio-Donahue CA. The pancreatic cancer genome revisited. NAT REV GASTRO HEPAT. 2021;18(7):469\u201381.","journal-title":"NAT REV GASTRO HEPAT"},{"issue":"6","key":"1539_CR32","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1097\/MPA.0000000000000372","volume":"44","author":"R Sinha","year":"2015","unstructured":"Sinha R, Gardner T, Padala K, Greenaway JR, Joy D. Double-Duct sign in the clinical context. Pancreas. 2015;44(6):967\u201370.","journal-title":"Pancreas"},{"issue":"1","key":"1539_CR33","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1067\/mge.2000.105775","volume":"52","author":"M Menges","year":"2000","unstructured":"Menges M, Lerch MM, Zeitz M. The double duct sign in patients with malignant and benign pancreatic lesions. GASTROINTEST ENDOSC. 2000;52(1):74\u20137.","journal-title":"GASTROINTEST ENDOSC"},{"issue":"4","key":"1539_CR34","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1007\/s00261-016-0979-1","volume":"42","author":"P Yadav","year":"2017","unstructured":"Yadav P, Lal H. Double duct sign. ABDOM RADIOL. 2017;42(4):1283\u20134.","journal-title":"ABDOM RADIOL"},{"issue":"6","key":"1539_CR35","doi-asserted-by":"publisher","first-page":"e98718","DOI":"10.1371\/journal.pone.0098718","volume":"9","author":"S Takano","year":"2014","unstructured":"Takano S, Fukasawa M, Maekawa S, Kadokura M, Miura M, Shindo H, Takahashi E, Sato T, Enomoto N. Deep sequencing of cancer-related genes revealed GNAS mutations to be associated with intraductal papillary mucinous neoplasms and its main pancreatic duct dilation. PLoS ONE. 2014;9(6):e98718.","journal-title":"PLoS ONE"},{"issue":"4","key":"1539_CR36","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1007\/s00330-021-08316-8","volume":"32","author":"S Han","year":"2022","unstructured":"Han S, Kim JH, Yoo J, Jang S. Prediction of recurrence after surgery based on preoperative MRI features in patients with pancreatic neuroendocrine tumors. EUR RADIOL. 2022;32(4):2506\u201317.","journal-title":"EUR RADIOL"},{"issue":"2","key":"1539_CR37","first-page":"188409","volume":"1875","author":"G Luo","year":"2021","unstructured":"Luo G, Jin K, Deng S, Cheng H, Fan Z, Gong Y, Qian Y, Huang Q, Ni Q, Liu C, et al. Roles of CA19-9 in pancreatic cancer: Biomarker, predictor and promoter. BBA-REV CANCER. 2021;1875(2):188409.","journal-title":"BBA-REV CANCER"},{"issue":"12","key":"1539_CR38","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1002\/cac2.12204","volume":"41","author":"J Yang","year":"2021","unstructured":"Yang J, Xu R, Wang C, Qiu J, Ren B, You L. Early screening and diagnosis strategies of pancreatic cancer: a comprehensive review. CANCER COMMUN. 2021;41(12):1257\u201374.","journal-title":"CANCER COMMUN"},{"issue":"10039","key":"1539_CR39","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0140-6736(16)00141-0","volume":"388","author":"T Kamisawa","year":"2016","unstructured":"Kamisawa T, Wood LD, Itoi T, Takaori K. Pancreatic cancer. Lancet. 2016;388(10039):73\u201385.","journal-title":"Lancet"},{"issue":"12","key":"1539_CR40","doi-asserted-by":"publisher","first-page":"e0227366","DOI":"10.1371\/journal.pone.0227366","volume":"14","author":"F Watanabe","year":"2019","unstructured":"Watanabe F, Suzuki K, Tamaki S, Abe I, Endo Y, Takayama Y, Ishikawa H, Kakizawa N, Saito M, Futsuhara K, et al. Longitudinal monitoring of KRAS-mutated circulating tumor DNA enables the prediction of prognosis and therapeutic responses in patients with pancreatic cancer. PLoS ONE. 2019;14(12):e0227366.","journal-title":"PLoS ONE"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-024-01539-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-024-01539-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-024-01539-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T17:02:41Z","timestamp":1734973361000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedimaging.biomedcentral.com\/articles\/10.1186\/s12880-024-01539-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,23]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1539"],"URL":"https:\/\/doi.org\/10.1186\/s12880-024-01539-3","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,23]]},"assertion":[{"value":"4 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in accordance with the Declaration of Helsinki, and approved by the ethics committee of Zhongshan Hospital, Fudan university (B2024-250R), which waived the requirement for written informed consent owing to the use of deidentified retrospective data. Clinical trial number: not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"349"}}